Home > Research > Publications & Outputs > ß-Hairpin mimics containing a piperidine-pyrrol...

Electronic data

  • Chem Sci (2016)

    Final published version, 1.24 MB, PDF document

    Available under license: CC BY


Text available via DOI:

View graph of relations

ß-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the ß-amyloid aggregation process preserving the monomer species

Research output: Contribution to journalJournal article

  • S. Pellegrino
  • N. Tonali
  • E. Erba
  • J. Kaffy
  • M. Taverna
  • A. Contini
  • Mark Neville Taylor
  • David Allsop
  • M. L. Gelmi
  • S. Ongeri
<mark>Journal publication date</mark>1/02/2017
<mark>Journal</mark>Chemical Science
Issue number2
Number of pages8
Pages (from-to)1295-1302
Publication statusPublished
Early online date7/10/16
Original languageEnglish


Alzheimer’s disease is a neurodegenerative disorder linked to oligomerization and fibrillization of amyloid β peptides, with Aβ1-42 being the most aggregative and neurotoxic one. We report herein the synthesis and conformational analysis of Aβ1-42-amyloid related β-hairpin peptidomimetics, built on a piperidine-pyrrolidine semi rigid β-turn inducer and bearing two small recognition peptide sequences, designed on oligomeric and fibril structures of Aβ1-42. According to these peptide sequences, a stable β-hairpin or a dynamic equilibrium between two possible architectures was observed. These original constructs are able to greatly delay the kinetics of Aβ1-42 aggregation process as demonstrated by thioflavin-T fluorescence, and transmission electron microscopy. Capillary electrophoresis indicates their ability to preserve the monomer species, inhibiting the formation of toxic oligomers. Furthermore, compounds protect against toxic effects of Aβ on neuroblastoma cells even at substoichiometric concentrations. This study is the first example of acyclic small β-hairpin mimics possessing such a highly efficient anti-aggregation activity. The protective effect is more pronounced than that observed with molecules which have undergone clinical trials. The structural elements made in this study provide valuable insights in the understanding of the aggregation process and insights to explore the design of novel acyclic β-hairpin targeting other types of amyloid-forming proteins.